RFK Jr. remains HHS Secretary more than a year after Senate confirmation, with ongoing White House alignment on Make America Healthy Again priorities including vaccine policy revisions, agency reorganizations, and leadership changes at FDA and CMS. Recent activity includes September 2026 budget testimony before Congress, keynote appearances, and continued implementation of departmental restructuring despite court injunctions on certain immunization schedule adjustments and criticism from health organizations. No public statements or credible reporting indicate resignation plans or removal proceedings through mid-September 2026. Traders price the 77% No outcome on this sustained institutional support and absence of triggering events such as confirmation battles, scandals, or policy reversals that could force an exit before year-end.
基於Polymarket數據的AI實驗性摘要。這不是交易建議,也不影響該市場的結算方式。 · 更新於$24,789 交易量
$24,789 交易量
$24,789 交易量
$24,789 交易量
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
市場開放時間: Mar 19, 2026, 2:02 PM ET
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
RFK Jr. remains HHS Secretary more than a year after Senate confirmation, with ongoing White House alignment on Make America Healthy Again priorities including vaccine policy revisions, agency reorganizations, and leadership changes at FDA and CMS. Recent activity includes September 2026 budget testimony before Congress, keynote appearances, and continued implementation of departmental restructuring despite court injunctions on certain immunization schedule adjustments and criticism from health organizations. No public statements or credible reporting indicate resignation plans or removal proceedings through mid-September 2026. Traders price the 77% No outcome on this sustained institutional support and absence of triggering events such as confirmation battles, scandals, or policy reversals that could force an exit before year-end.
基於Polymarket數據的AI實驗性摘要。這不是交易建議,也不影響該市場的結算方式。 · 更新於


警惕外部連結哦。
警惕外部連結哦。
Frequently Asked Questions